View
224
Download
0
Category
Preview:
Citation preview
7/30/2019 GNIPST Bulletin 21.2
1/13
1
1118-1177-4796-9849-7562-5062mail
GNIPST BULLETIN 2012
28th
December 2012 Volume No.: 21 Issue No.: 0
Contents Message from GNIPS
Letter to the Editor News Update
Disease Outbreak Ne
Health Awareness
Forth Coming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive
Vision
TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O
PHARMACEUTICAL AND BIOLOGICAL SCIENCE
EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND
TECHNOLOGY
GNIPST Photo Gallery
For your comments/contribution
ack-Issues,
mailto:gnipstbulletin@gmail.com
https://picasaweb.google.com/111714720327580099858/FreshersWelcome20122012mailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.comhttps://picasaweb.google.com/111714720327580099858/FreshersWelcome201220127/30/2019 GNIPST Bulletin 21.2
2/13
28-12-2012
Click here to go at the top
MESSAGE FROM GNIPST
All the members of GNIPST are proud to publish the 21st
Volume
of GNIPST BULLETIN. This bulletin has successfully
completed its twenty months journey. We hope it has kept the
readers updated of recent activities in pharmaceutical & biological
sciences and also introduced them with the different activities of
our esteemed institution. We are thankful to all of you for your
great cooperation & support and are looking forward to the same in
future.
LETTER TO THE EDITOR.
NEWS UPDATE
A New Type of Nerve Cell Found in the Brain.
(21DECEMBER 2012
)An international team of scientists has identified a previously
unknown group of nerve cells in the brain. The nerve cells regulate
cardiovascular functions such as heart rhythm and blood pressure.
It is hoped that the discovery will be significant in the long term in
the treatment of cardiovascular diseases in humans. Rebuilding Blood Vessels Through Gene Therapy
(21 DECEMBER 2012)
1
http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221123504.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%297/30/2019 GNIPST Bulletin 21.2
3/13
28-12-2012
Click here to go at the top
Diagnosed with severe coronary artery disease, a group of patients
too ill for or not responding to other treatment options decided to
take part in a clinical trial testing angiogenic gene therapy to help
rebuild their damaged blood vessels.
Understanding Cell Organization to Tackle
Cancer(23 DECEMBER 2012)
Scientists have identified how cells know which way up they need
to be. The discovery could help in the fight against cancer becausein the early stages of the disease the cells become dis-organized.
New Class of Malaria Drugs Using Essential
Calcium Enzyme Developed(14 DECEMBER 2012)
Calpain, a calcium-regulated enzyme, is essential to a host of
cellular processes, but can cause severe problems in its
overactivated state, and has been implicated in several diseases.
Researchers have developed a unique approach to calpain
inhibition by mimicking a natural reaction with a synthesized
molecule.
2
http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121223152622.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121227142953.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121223152622.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2012/12/121221081441.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%297/30/2019 GNIPST Bulletin 21.2
4/13
28-12-2012
Click here to go at the top
HEALTH AWARENESS
Climate Change and Health
Climate change
Over the last 50 years, human activities particularly the burning
of fossil fuels have released sufficient quantities of carbon
dioxide and other greenhouse gases to trap additional heat in the
lower atmosphere and affect the global climate.
In the last 100 years, the world has warmed by approximately 0.750C. Over the last 25 years, the rate of global warming has
accelerated, at over 0.18 0C per decade.
Sea levels are rising, glaciers are melting and precipitation patterns
are changing. Extreme weather events are becoming more intense
and frequent.
What is the impact of climate change on health?
Although global warming may bring some localized benefits, such
as fewer winter deaths in temperate climates and increased food
production in certain areas, the overall health effects of a changing
climate are likely to be overwhelmingly negative. Climate change
affects social determinants of health clean air, safe drinking
water, sufficient food and secure shelter.
3
7/30/2019 GNIPST Bulletin 21.2
5/13
28-12-2012
Click here to go at the top
Extreme heat
Extreme high air temperatures contribute directly to deaths from
cardiovascular and respiratory disease, particularly among elderlypeople. In the heat wave of summer 2003 in Europe for example,
more than 70 000 excess deaths were recorded.
High temperatures also raise the levels of ozone and other
pollutants in the air that exacerbate cardiovascular and
respiratory disease. Urban air pollution causes about 1.2 milliondeaths every year.
Pollen and other aeroallergen levels are also higher in extreme
heat. These can trigger asthma, which affects around 300 million
people. Ongoing temperature increases are expected to increase
this burden.
Natural disasters and variable rainfall patterns
Globally, the number of reported weather-related natural disasters
has more than tripled since the 1960. Every year, these disasters
result in over 60 000 deaths, mainly in developing countries.
Rising sea levels and increasingly extreme weather events will
destroy homes, medical facilities and other essential services. More
than half of the world's population lives within 60 km of the sea.
People may be forced to move, which in turn heightens the risk of
4
7/30/2019 GNIPST Bulletin 21.2
6/13
28-12-2012
Click here to go at the top
a range of health effects, from mental disorders to communicable
diseases.
Increasingly variable rainfall patterns are likely to affect the supplyof fresh water. A lack of safe water can compromise hygiene and
increase the risk of diarrhoeal disease, which kills 2.2 million
people every year. In extreme cases, water scarcity leads to
drought and famine. By the 2090, climate change is likely to widen
the area affected by drought, double the frequency of extreme
droughts and increase their average duration six-fold3.
Floods are also increasing in frequency and intensity. Floods
contaminate freshwater supplies, heighten the risk of water-borne
diseases, and create breeding grounds for disease-carrying insects
such as mosquitoes. They also cause drownings and physical
injuries, damage homes and disrupt the supply of medical and
health services.
Rising temperatures and variable precipitation are likely to
decrease the production of staple foods in many of the poorest
regions by up to 50% by 2020 in some African countries4. This
will increase the prevalence of malnutrition and undernutrition,
which currently cause 3.5 million deaths every year.
Patterns of infection
5
7/30/2019 GNIPST Bulletin 21.2
7/13
28-12-2012
Click here to go at the top
Climatic conditions strongly affect water-borne diseases and
diseases transmitted through insects, snails or other cold blooded
animals.
Changes in climate are likely to lengthen the transmission seasons
of important vector-borne diseases and to alter their geographic
range. For example, climate change is projected to widen
significantly the area of China where the snail-borne disease
schistosomiasis occurs.
Malaria is strongly influenced by climate. Transmitted by
Anopheles mosquitoes, malaria kills almost 1 million people every
year mainly African children under five years old. The Aedes
mosquito vector of dengue is also highly sensitive to climate
conditions. Studies suggest that climate change could expose an
additional 2 billion people to dengue transmission by the 2080.
Measuring the health effects
Measuring the health effects from climate change can only be very
approximate. Nevertheless, a WHO assessment, taking into
account only a subset of the possible health impacts, concluded
that the modest warming that has occurred since the 1970s was
already causing over 140 000 excess deaths annually by the year
2004.
6
7/30/2019 GNIPST Bulletin 21.2
8/13
28-12-2012
Click here to go at the top
Who is at risk?
All populations will be affected by climate change, but some are
more vulnerable than others. People living in small islanddeveloping states and other coastal regions, megacities, and
mountainous and polar regions are particularly vulnerable.
Children in particular, children living in poor countries are
among the most vulnerable to the resulting health risks and will be
exposed longer to the health consequences. The health effects arealso expected to be more severe for elderly people and people with
infirmities or pre-existing medical conditions.
Areas with weak health infrastructure mostly in developing
countries will be the least able to cope without assistance to
prepare and respond.
DISEASE OUTBREAK NEWS
FORTHCOMING EVENTS
IPSCON-2012 45th Annual Conference of Indian Pharmacological
Society and International Conference on 'Navigating Pharmacology
towards Safe and Effective Therapy'
7
7/30/2019 GNIPST Bulletin 21.2
9/13
28-12-2012
Click here to go at the top
Dates 04 Jan 2013 07 Jan 2013
Location: Nagpur, Maharashtra, India.
DRUGS UPDATES
FDA approves new orphan drug for rare
cholesterol disorder (26 DECEMBER 2012)
The U.S. FDA approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol,
apolipoprotein B, and non-high-density lipoprotein (non-HDL)
cholesterol in patients with homozygous familial
hypercholesterolemia (HoFH). Juxtapid is intended for use in
combination with a low fat diet and other lipid-lowering
treatments.
FDA approves Eliquis to reduce the risk of
stroke, blood clots in patients. (28 DECEMBER 2012)
The U.S. FDA approved the anti-clotting drug Eliquis (apixaban),
an oral tablet used to reduce the risk of stroke and dangerousblood clots (systemic embolism) in patients with atrial fibrillation
that is not caused by a heart valve problem.
8
http://www.ipsnagpur2012.org/http://www.ipsnagpur2012.org/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333285.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333634.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333285.htmhttp://www.ipsnagpur2012.org/7/30/2019 GNIPST Bulletin 21.2
10/13
28-12-2012
Click here to go at the top
CAMPUS NEWS
Two of our faculties Dr. Prerona Saha and Dr. Sriporna Kundu Sen
were awarded Ph.D (Pharmaceutical Chemistry) in the Department
of Pharmaceutical Technology, Jadavpur University, Kol-32 in the
annual convocation organized on 24th
December, 2012.
STUDENTS SECTION
WHO CAN ANSWER FIRST???() Which parasite was named after physician
and parasitologist
?
() Which is considered as ?
A) Chess B) Indian Air force
gnipstbulletin@gmail.com
EDITORS NOTE
I am very happy to publish the 2nd
issue of 21st
Volume of GNIPST
BULLETIN. It is my great pleasure to introduce you to the newly
9
mailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.com7/30/2019 GNIPST Bulletin 21.2
11/13
28-12-2012
Click here to go at the top
launched facebook account GNIPST bulletin. You are cordially
invited to add this account to your friend list. The current issues will
also be directly available on facebook.
I would like to convey my thanks to all the GNIPST members and
the readers for their valuable comments, encouragement& supports.
Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya
Bhattacharya, for his contribution in students section.
It would be my great pleasure to receive the contributions,
suggestions & feedback from your desk for further upliftment of thisdeliberation GNIPST BULLETIN.
ARCHIVE
The general body meeting of APTI, Bengal Branch has been
conducted at GNIPST on 15
th
June, 2012. The programme startedwith a nice presentation by Dr. Pulok Kr. Mukherjee, School of
Natural Products, JU on the skill to write a good manuscript for
publication in impact journals. It was followed by nearly two hour
long discussion among more than thirty participants on different
aspects of pharmacy education. Five nonmember participants
applied for membership on that very day.
GNIPST is now approved by AICTE and affiliated to WBUT for
conducting the two years post graduate course (M.Pharm) in
The approved number of seat is 18.
10
7/30/2019 GNIPST Bulletin 21.2
12/13
28-12-2012
Click here to go at the top
The number of seats in B.Pharm. has been increased from 60 to
120.
2
nd
World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and
Dosimetry (SWC-2013) : On the Way to Personalized Medicine
Dates 28 Feb 2013 02 Mar 2013
Location: Chandigarh, India.
5-Days Hands-on Workshop on Molecular Biotechnology and Bioinformatics.
7thto 11th January 2013, Pune, Maharashtra, India.
IAMLE- 2013 4th International Conference on Medical Negligence and
litigation in Medical Practice, and 4th International Conference on Recent
Advances in Forensic Sciences, Forensic Medicine & Toxicology.
Date: 25 Jan 2013 27 Jan 2013, Location: Kovalam, Thiruvanthapuram,
India.
will be held from
, at Chennai. The four-day event will be
organized by the Association of Pharmacy Teachers of India (APTI).
11
http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.icsccb.org/workshops/http://www.icsccb.org/workshops/http://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.iamleconf.in/homehttp://www.icsccb.org/workshops/http://www.2ndworldcongress-ga-68.de/7/30/2019 GNIPST Bulletin 21.2
13/13
28-12-2012
Click here to go at the top
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-
13 to GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of
Pharmaceutical Science & Technology.
b. Principal Investigator: Dr. Lopamudra Dutta.
c. Grant-in-aid sanctioned: Rs. 16,25000/- only
d.Approved duration: 3 years
e. Title of the project: Screening and identification of
potential medicinal plant ofPurulia & Bankura districts of West
Bengal with respect to diseases such as diabetes, rheumatism,
Jaundice, hypertension and developing biotechnological tools for
enhancing bioactive molecules in these plant.
Special classes on Communication Skills, G.D. and
Interview will commence from 3rd week of January 2013
for the students of this Institute. Interested students are
required to contact the undersigned for enrolment either
personally or by e-mail.
Dr. Lopamudra Datta
E-mail: info.gnipst@jisgroup.org
gnipstbulletin@gmail.com
12
mailto:info.gnipst@jisgroup.orgmailto:info.gnipst@jisgroup.orgmailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.commailto:gnipstbulletin@gmail.commailto:info.gnipst@jisgroup.orgRecommended